Olema Pharmaceuticals files mixed shelf offering

OLMA Stock  USD 4.11  0.09  2.14%   
About 76 percent of Olema Pharmaceuticals' investors are selling. The analysis of the overall investor sentiment regarding Olema Pharmaceuticals suggests that a fairly large number of traders are terrified. The current market sentiment, together with Olema Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Olema Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
  
Olema Pharmaceuticals has filed for a mixed shelf offering of up to 200M according to an SEC Filing.

Read at seekingalpha.com
seekingalpha News
  

Olema Pharmaceuticals Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Olema Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Olema Pharmaceuticals Fundamental Analysis

We analyze Olema Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Olema Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Olema Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Beta

Beta Comparative Analysis

Olema Pharmaceuticals is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.

Olema Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Olema Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Olema Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Olema Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Olema Pharmaceuticals Related Equities

NVCTNuvectis Pharma   8.39   
0%
100.0%
MOLNMolecular Partners   6.05   
0%
72.0%
PHVSPharvaris   1.48   
0%
17.0%
ZNTLZentalis Pharmaceuticals   1.12   
0%
13.0%
FENCFennec Pharmaceuticals   0.62   
0%
7.0%
CNTACentessa Pharmaceuticals   0.55   
0%
6.0%
DSGNDesign Therapeutics   0.48   
0%
5.0%
IRONDisc Medicine   0.21   
2.0%
0%
ERASErasca   1.94   
23.0%
0%
LRMRLarimar Therapeutics   2.08   
24.0%
0%
MLYSMineralys Therapeutics,   2.27   
27.0%
0%
GLUEMonte Rosa   3.04   
36.0%
0%
CGEMCullinan Oncology   3.26   
38.0%
0%
ANTXAN2 Therapeutics   3.47   
41.0%
0%
OBIOOrchestra BioMed   4.35   
51.0%
0%
SANASana Biotechnology   7.57   
90.0%
0%
PEPGPepGen   8.07   
96.0%
0%

Complementary Tools for Olema Stock analysis

When running Olema Pharmaceuticals' price analysis, check to measure Olema Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Olema Pharmaceuticals is operating at the current time. Most of Olema Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Olema Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Olema Pharmaceuticals' price. Additionally, you may evaluate how the addition of Olema Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Global Correlations
Find global opportunities by holding instruments from different markets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data